Flow Cytometry – News and Features

Dr. Andreas Boehmler explores how the arrival of new flow cytometry platforms finally puts powerful automation within reach for many labs, allowing operators to enumerate stem cells more quickly and accurately for transplant.

A powerful imaging mass cytometry technique has been used for the first time to examine the kidneys of people with lupus, which could help identify drug targets and novel disease markers.

Researcher publishes a study identifying 135 previously unknown pigmentation genes with broad implications for human diversity, cell biology and medicine.

Technology Networks had the pleasure of speaking with Dr. Maddison Masaeli, co-founder and chief executive officer at Deepcell to learn about the REM-I platform, a single-cell analysis tool that utilizes AI-powered imaging to magnify insights into a cell’s phenotype and function.

Scientists investigate link between "deprogrammed" regulatory T cells and cardiovascular disease.

Cases of head and neck cancers that are associated with HPV infection are on the rise in the US, and new research has divided these cancers into two subtypes that determine how well patients respond to treatment.

Researchers have developed a technique called diffuse in-vivo flow cytometry (DiFC) to detect and count the number of circulating tumor cells.

Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.

A new, ultra-high-resolution map of cell neighborhoods proves your intestine is both functionally impressive and visually striking.

A team of researchers has now shown that PFAS can also reduce the activity of human immune cells and thus impair health.